Literature DB >> 10428257

Dendritic cells as regulators of immune reactivity: implications for transplantation.

A W Thomson1, L Lu.   

Abstract

Dendritic cells are now regarded not only as the initiators but also as regulators of immune responses. They are potentially powerful tools for the therapeutic manipulation of immune reactivity in cancer, infectious disease, and allograft rejection. We provide a brief overview of the properties of dendritic cells, with emphasis on recently acquired information, then focus attention on their capacity to modulate immune reactivity, and its relevance to transplantation.

Entities:  

Mesh:

Year:  1999        PMID: 10428257     DOI: 10.1097/00007890-199907150-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

Review 1.  Cellular and molecular biology of cardiac transplant rejection.

Authors:  T J Dengler; J S Pober
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

Review 2.  Challenges to achieving clinical transplantation tolerance.

Authors:  A D Salama; G Remuzzi; W E Harmon; M H Sayegh
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 3.  Regulatory dendritic cells for human organ transplantation.

Authors:  Angus W Thomson; Diana M Metes; Mohamed B Ezzelarab; Dalia Raïch-Regué
Journal:  Transplant Rev (Orlando)       Date:  2019-05-13       Impact factor: 3.943

Review 4.  Facilitating physiologic self-regeneration: a step beyond islet cell replacement.

Authors:  Pleunie P M Rood; Rita Bottino; A N Balamurugan; Yong Fan; David K C Cooper; Massimo Trucco
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

5.  Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts.

Authors:  Ping Yu; Sidong Xiong; Qiuzao He; Yiwei Chu; Chi Lu; Charmaine A Ramlogan; Jason C Steel
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

6.  Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions.

Authors:  Rolf Spirig; Siamak Djafarzadeh; Tomas Regueira; Sidney G Shaw; Christophe von Garnier; Jukka Takala; Stephan M Jakob; Robert Rieben; Philipp M Lepper
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

7.  Stratification of Antigen-presenting Cells within the Normal Cornea.

Authors:  Jared E Knickelbein; Simon C Watkins; Paul G McMenamin; Robert L Hendricks
Journal:  Ophthalmol Eye Dis       Date:  2009-11-25

8.  Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival.

Authors:  Min Zhu; Ming-Fa Wei; Fang Liu; Hui-Fen Shi; Guo Wang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

Review 9.  Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus.

Authors:  Nick Giannoukakis; Massimo Trucco
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 9.306

10.  Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment.

Authors:  Isabelle J Fugier-Vivier; Francine Rezzoug; Yiming Huang; Amanda J Graul-Layman; Carrie L Schanie; Hong Xu; Paula M Chilton; Suzanne T Ildstad
Journal:  J Exp Med       Date:  2005-02-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.